Purchase Order 75N93025P01091

Award Date 9/26/25
Potential Completion Date 9/25/26
Potential Value $249K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Potomac, MD 20854, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Speed Biosystems, LLC, a minority-owned, small disadvantaged business. The $96,753.00 firm fixed-price purchase order is for the supply of 20mL of TURBO293 Transfection Reagent, a specialized biological research product used in coronavirus-related research, vaccine production, and immunogen development. The contract has no set-aside...
This federal contract award was made by the Department of Health and Human Services' National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases (NIAID) to Speed Biosystems, LLC, a minority-owned, small disadvantaged business. The $146,750.00 firm fixed price purchase order is for the delivery of 70 units of Speed Biosystems' proprietary TURBO293 transfection reagent, which is critical for coronavirus-related research, vaccine development, and production of...
This is a sole-source purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Speed Biosystems, LLC, a minority-owned small disadvantaged business. The $146,860.00 firm-fixed-price contract is for the delivery of 46 units of TURBO293 Transfection Reagents, a specialized biological product used in coronavirus-related research, vaccine production, and immunogen development. The contract supports critical...
The Department of Health and Human Services' National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases (NIAID) awarded a firm-fixed-price purchase order to Speed Biosystems, LLC for the provision of COVID-19 TURBO 293 transfection reagents. The contract, valued at $148,325.00, has a period of performance through June 8, 2023. Speed Biosystems is a minority-owned, small disadvantaged business that has previously received over $3 million in prime federal contracts...
This is a sole-source, firm-fixed price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a part of the U.S. Department of Health and Human Services, to Speed Biosystems, LLC, a minority-owned, small disadvantaged business. The $248,980.00 contract is for the delivery of 78 units of TURBO293 Transfection Reagents to support coronavirus research, vaccine production, and immunogen development at NIAID facilities in Maryland. The award is not set aside and...
The Department of Health and Human Services, National Institutes of Health (NIH), National Institute of Allergy and Infectious Diseases (NIAID) awarded a firm fixed price purchase order to Speed Biosystems, LLC, a self-certified small disadvantaged and minority-owned business. The $146,600.00 contract is for the provision of TURBO293 transfection reagents, kits, protocols, and continuity support to aid coronavirus-related research at NIH labs and the Vaccine Research Center. The contract does...
This federal contract award was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the U.S. Department of Health and Human Services, to Speed Biosystems, LLC, a minority-owned and small disadvantaged business. The $99,345.00 firm-fixed price purchase order is for the supply of 500 units of Speed Biosystems' proprietary TURBO293 Transfection Reagent, a key product used in coronavirus-related research, vaccine production, and the development of immunogens...
The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $123,192.00 firm fixed price purchase order contract to Speed Biosystems, LLC, a minority-owned small disadvantaged business. The contract is for the provision of TURBO293 transfection reagents, kits, protocols, and continuity support to aid coronavirus-related research at NIH labs and the Vaccine Research Center. This sole-source award was made under the...
The Department of Health and Human Services' National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases (NIAID) awarded a firm-fixed-price purchase order to Speed Biosystems, LLC, a minority-owned small disadvantaged business, for the provision of TURBO293 transfection reagents. The $248,980.00 contract supports coronavirus-related research at NIH labs and the Vaccine Research Center. The award was sole-sourced to Speed Biosystems as the proprietary developer of...
The Department of Health and Human Services' National Institutes of Health National Institute of Allergy and Infectious Diseases (NIH NIAID) awarded a $683,400.00 firm fixed price purchase order contract to Speed Biosystems, LLC, a minority-owned small disadvantaged business, for the provision of TURBO293 transfection reagents, kits, protocols, and continuity support. The contract, which did not involve set-asides or subcontractors, was sole-sourced to Speed Biosystems as the proprietary...

This federal contract award was made by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Speed Biosystems, LLC, a minority-owned small disadvantaged business located in Rockville, Maryland. The $248,930.00 firm fixed-price purchase order is for the delivery of 78 units of TURBO293 Transfection Reagent, a specialized biological research product critical for coronavirus-related studies, vaccine production, and immunogen development. This sole-source procurement, which does not utilize any set-aside designations, aligns with NIAID's continuity protocols and compatibility requirements, as Speed Biosystems is the sole owner, developer, and seller of the required reagents. The contract supports research activities at the NIH's Vaccine Research Center in Bethesda, Maryland. Since 2019, Speed Biosystems has received over $3 million in federal contracts from NIAID and the National Cancer Institute, demonstrating its significant role in supporting critical scientific research infrastructure.

Generated 9/26/25, 9:53 AM